Department of Pathology, the Second Xiangya Hospital, Central South University, Changsha 410011, China.
School of Basic Medicine, Health Science Center, Hubei University of Arts and Science, Xiangyang 441053, China.
J Zhejiang Univ Sci B. 2024 Sep 15;25(9):796-799. doi: 10.1631/jzus.B2400013.
Type 1 diabetes (T1D) is a T lymphocyte-mediated autoimmune disease caused by pancreatic β-cell destruction, which eventually leads to reduced insulin level and increased blood glucose level (Syed, 2022). As a multifactorial disease, T1D is characterized by a genetic predisposition associated with various environmental and cellular elements (Syed, 2022). Pancreatic β cells have long been considered the "innocent victims" in T1D pathogenesis since the pancreas is attacked by the immune cells, resulting in a process known as insulitis, in which the immune cells infiltrate pancreatic islets and secrete pro-inflammatory cytokines. However, growing evidence suggests that various β-cell stresses, dysfunction, and death contribute to T1D pathogenesis, as it has been observed that β-cell dysfunction in autoantibody-positive (Aab) individuals exists long before T1D diagnosis (Evans-Molina et al., 2018).
1 型糖尿病(T1D)是一种由胰腺β细胞破坏引起的 T 淋巴细胞介导的自身免疫性疾病,最终导致胰岛素水平降低和血糖水平升高(Syed,2022)。作为一种多因素疾病,T1D 的特征是遗传易感性与各种环境和细胞因素相关(Syed,2022)。由于胰腺受到免疫细胞的攻击,胰岛发生炎症浸润,即所谓的胰岛炎,β 细胞长期以来被认为是 T1D 发病机制中的“无辜受害者”,在此过程中,免疫细胞浸润胰岛并分泌促炎细胞因子。然而,越来越多的证据表明,各种β细胞应激、功能障碍和死亡导致了 T1D 的发病机制,因为已经观察到在 T1D 诊断之前,自身抗体阳性(Aab)个体中就存在β细胞功能障碍(Evans-Molina 等人,2018)。